Awarded Organization: University of California, Irvine
Awarded Department: Department of Physiology and Biophysics
Sponsor: Dr. Scott E FraserAward Year Start: 1991
Current Organization: Winthrop University
Current Department: Department of Biology
Current Title: Professor
Project Title: Patterning and segmentation in the nervous system
Awarded Organization: Whitehead Institute
Awarded Department: Sabatini Laboratory
Sponsor: Dr. David SabatiniAward Year Start: 2010
Current Organization: The Rockefeller University
Current Department: Laboratory of Metabolic Regulation and Genetics
Current Title: Associate Professor
Project Title: Diet-dependent regulation of tumor growth through stroma metabolism
Awarded Organization: University of California, Berkeley
Awarded Department: Department of Molecular and Cellular Biology
Sponsor: Dr. Susan MarquseeAward Year Start: 2022
Current Organization: University of California, Berkeley
Current Department: Department of Chemistry
Current Title: Postdoctoral Fellow
Project Title: An unprecedented atomistic picture of co-translational protein folding
The majority of functions we associate with living thing are made possible thanks to the molecular functions of proteins. Proteins, just like cars and other macroscopic machines, require a specific 3D structure in order to be able to perform their functions and improper protein folding is linked to diseases cut as Alzheimer’s, Parkinson’s, and various cancers. Yet despite decades of research, we still do not understand how proteins fold up into these structures, and what determines whether folding ultimately proceeds correctly—these questions are not addressed by structure-prediction algorithms such as DeepMind’s AlphaFold. It is crucial that we make progress on these issues if we are to rationally design treatments for misfolding diseases, and to predict evolution of organisms, which is often mediated by changes to protein folding and function.
All proteins are made up of one or more chains of amino acids. For some proteins, the physical and chemical interactions between these amino acids are entirely sufficient to drive protein folding into correct native structure. But growing evidence suggests that, for many other proteins, these interactions instead cause the amino acid chain to misfold into non-functional molecular structures. A major goal of my research is to understand how this conundrum is resolved in the complex cellular environment.
One possible resolution to this issue may lie in the fact that, in addition to folding, a protein molecule needs to be synthesized one amino acid at a time by the ribosome. It turns out that many proteins can start folding as they are being synthesized, a process known as co-translational folding which has been shown to significantly increase the odds that certain proteins fold correctly. Indeed, many proteins contain evolutionarily conserved slowdowns in their rate of synthesis at chain lengths corresponding to putative co-translational folding intermediates, indicating it is broadly useful to modulate synthesis rates to give time for co-translational folding. This is akin to how dance (analogous to a chain’s folding) is closely linked to musical rhythm (how quickly amino acids are added)—I may have taken this analogy a bit too far and written a musical piece inspired by it (The Dance of the Nascent Chain).
My research aims to develop a detailed molecular picture of this process, and why it is beneficial to fold co-translationally for many proteins, by combining in vitro and in vivo experimental techniques, physics theory and atomistic simulations. In the future, this interdisciplinary pipeline can also be applied to investigate additional complex processes in the cell including mechanisms of misfolding in disease.
Awarded Organization: Massachusetts General Hospital
Awarded Department: Department of Pathology
Sponsor: Dr. Jonathan WhetstineAward Year Start: 2009
Current Organization: University of Colorado Anschutz Medical Campus
Current Department: Department of Pharmacology
Current Title: Associate Professor
Project Title: Histone lysine tri-demethylases regulate cell cycle progression
I am studying how chromatin structure contributes to transcription, DNA replication, differentiation and maintaining genome stability.  My research is focused on how the JMJD2 family of histone tri-demethylases are involved in regulating these processes.
I received BS degrees in biology and chemistry/biochemistry from Worcester Polytechnic Institute, where I became interested in understanding how the expression of genes was controlled to coordinate differentiation and development.¬†¬† I received my PhD at UCLA where, in Michael Carey’s laboratory, I developed a reconstituted chromatin system to begin to elucidate the biochemical events required prior to gene transcription.¬† My research uncovered an interaction between the critically important Mediator co-activator complex and the chromatin regulator p300. In post-doctoral work in the laboratory of Jonathan Whetstine, I am studying how the JMJD2 family of histone tri-demethylases regulates chromatin structure and gene expression.¬† I have uncovered an important role for one of these enzymes, JMJD2A, in DNA replication and cell cycle progression.¬† Since these enzymes are amplified in numerous cancers and important for maintaining genomic stability, this work has potential to lead to new cancer therapies.
Awarded Organization: University of Geneva
Awarded Department: Institut de Biologie Moleculaire
Sponsor: Dr. Edward KellenbergerAward Year Start: 1967
Current Organization: University of Maryland School of Medicine
Current Department: Department of Biochemistry and Molecular Biology
Current Title: Professor
Project Title: Mechanisms for the assembly of bacteriophage +4
Awarded Organization: Harvard University
Awarded Department: Department of Chemistry and Chemical Biology
Sponsor: Dr. Stuart L SchreiberAward Year Start: 1999
Current Organization: University of Wisconsin-Madison
Current Department: Department of Chemistry
Current Title: Professor
Project Title: Explore Fas signaling with a synthetic trimerizer
Awarded Organization: New York Genome Center
Awarded Department: New York Genome Center
Sponsor: Dr. Rahul SatijaAward Year Start: 2021
Current Organization: New York Genome Center
Current Title: Postdoctoral Fellow
Project Title: A novel single-cell phospho-protein and chromatin accessibility assay
Protein phosphorylation is a fundamental, dynamic process that can have drastic effects on cellular physiology. Mutations in kinases, the enzymes that phosphorylate other proteins, are often implicated in neurological disease. Understanding the context and consequences of protein phosphorylation in different cell types throughout neurodevelopment is imperative to developing new treatments as well as our basic understanding of cell biology. Recent technological developments permit the simultaneous quantification of protein levels, chromatin accessibility and gene expression from single cells (DOGMA-Seq). I am extending this technology to quantify both phosphorylated proteins and total proteins as well as chromatin accessibility and gene expression. I am applying this assay at discrete timepoints throughout in vitro neurodevelopment to reveal previously uncharacterized cell-type specific signaling patterns affecting gene expression and ultimately, cell fate decisions.
Dana-Farber Cancer Institute
Read more
Awarded Organization: Dana-Farber Cancer Institute
Awarded Department: Department of Pediatric Oncology
Sponsor: Dr. Mariella FilbinAward Year Start: 2026
Current Title: Postdoctoral Fellow
Project Title: Targeting Developmental GABAergic Signaling in Diffuse Hemispheric Gliomas with H3G34 Mutations
Pediatric brain tumors arise in the developing brain, yet how they interact and communicate with their neighboring cells to promote tumor growth is not well understood. In Laura Blasco-Chamarro’s previous research she discovered how neural stem cells pause cell division to maintain a quiescent state. Now, as a Hope Funds for Cancer Research – Jane Coffin Childs Fellow, Blasco-Chamarro will study how pediatric brain tumors, called gliomas, misuse normal developmental programs to trigger abnormal cell division.
As a graduate student in Isabel Fariñas’ lab at the University of Valencia, Blasco-Chamarro explored how localized cues support neural stem cell (NSC) quiescence. She found that in response to a specific signal, NSCs secrete a supportive material, called the extracellular matrix (ECM) that induces quiescence. This matrix then activates specific proteins called YAP and TAZ, which move into the nucleus and turn on genes that reinforce the resting state. Her work showed how a cell’s environment can push neural stem cells toward staying inactive.
In Dr. Mariella Filbin’s lab at Dana-Farber Cancer Institute, Blasco-Chamarro will study the opposite process: how pediatric high-grade gliomas activate developmental signaling to keep dividing. She will map how tumor cells interact with surrounding cells in the tumor microenvironment and identify the signals that promote tumor growth. She expects that blocking these support signals could slow or stop tumor growth. This research could lead to new treatments for pediatric high-grade gliomas and offer a broader strategy for targeting similar, lineage-specific signaling pathways in other cancers.
Awarded Organization: University of Colorado, Boulder
Awarded Department: Department of Molecular, Cellular and Developmental Biology
Sponsor: Dr. Larry SollAward Year Start: 1976
Project Title: Characterization of E coli translational mutants
Awarded Organization: Stanford University
Awarded Department: Department of Cell Biology
Sponsor: Dr. James A SpudichAward Year Start: 1985
Current Organization: Stanford University
Current Department: Department of Applied Physics
Current Title: Professor Emeritus
Project Title: Measurement of myosin movement along actin filaments
Awarded Organization: University of California, Santa Barbara
Awarded Department: Department of Biological Sciences
Sponsor: Dr. John CarbonAward Year Start: 1980
Current Organization: University of North Carolina at Chapel Hill
Current Department: Department of Biology
Current Title: Professor
Project Title: Protein binding to yeast centromeric DNA
Awarded Organization: Cancer Research UK (CRUK)
Awarded Department: Department of RNA Tumor Virus Studies
Sponsor: Dr. G. S. MartinAward Year Start: 1972
Project Title: Virions of RNA tumor viruses
Awarded Organization: University of California, San Francisco
Awarded Department: Department of Cellular and Molecular Pharmacology
Sponsor: Dr. Dyche MullinsAward Year Start: 2007
Project Title: ParM plays a central role in bacterial plasmid segregation
University of California, San Francisco
Read more
Awarded Organization: University of California, San Francisco
Awarded Department: Department of Biochemistry and Biophysics
Sponsor: Dr. Cynthia KenyonAward Year Start: 2014
Current Organization: Louisiana State University
Current Department: Department of Biological Sciences
Current Title: Assistant Professor
Project Title: Germline rejuvenation in C. elegans
The survival of a species requires that age must be reset with each generation. How germ cells, the reproductive cells of animals, accomplish this feat remains a fundamental, unsolved question in biology.
Utilizing the genetically-tractable nematode¬†Caenorhabditis elegans,¬†my research aims to identify mechanisms that cleanse the germ lineage of cellular damage and thereby allow for trans-generational rejuvenation. As a JCC fellow in Dr. Cynthia Kenyon’s lab, I have uncovered a regulatory switch that links damage elimination to fertilization and establishes a clean slate for the next generation prior to embryogenesis. Currently, I am exploring the molecular underpinnings of this switch in more detail.
Because molecules that ensure the immortality of the germ lineage might be capable of rejuvenating diverse cell types, I am also testing whether these natural age-reversal strategies can be co-opted in somatic tissues. If so, mechanisms important for germline immortality might provide a promising entry point for reversing whole-organism aging.
University of California, San Francisco
Read more
Awarded Organization: University of California, San Francisco
Awarded Department: Department of Cellular and Molecular Pharmacology
Sponsor: Dr. Jonathan WeissmanAward Year Start: 2014
Current Organization: Helix
Current Department: Human Genetics
Current Title: Principal Investigator
Project Title: Regulation of gene expression by ribosomal proteins
Awarded Organization: Salk Institute for Biological Studies
Awarded Department: NOMIS Center for Immunobiology and Microbial Pathogenesis
Sponsor: Dr. Janelle AyresAward Year Start: 2026
Current Title: Postdoctoral Fellow
Project Title: Hypothalamic inflammation and metabolism in sepsis outcomes
There are two ways the body survives an infection, the immune system can kill the germ, or the body can reduce harm from the infection even if the germ isn’t eliminated.
Annalise Bond, Ph.D., created a new research tool during her Ph.D. that improved our understanding of how immune cells identify and destroy targets. As a Jane Coffin Childs Fellow, she will now focus on the second strategy—helping the body tolerate infection and limit damage, known as “cooperative defense”.
During Bond’s graduate work in Meghan Morrissey’s lab at UC Santa Barbara, she studied how macrophages (immune cells that act as the first responders) pick out pathogens among many healthy cells. She realized that the field lacked a tool to precisely control the duration and intensity of macrophage signaling, so she designed a synthetic, light-activated switch to turn on the signal. Using it, she showed that earlier activation can “prime” macrophages to engulf more of their target (in her experiments, cancer cells). She also found this priming works through a fast mechanism and a longer-lasting one, making the effect both quick and durable. These insights could help researchers design better ways to regulate immune responses, including against cancer.
Much less is known about the mechanisms of cooperative defense, which also means that this strategy remains essentially untapped in terms of therapeutic interventions. Dr. Bond will shift her studies to cooperative defense in Janelle Ayres, Ph.D.’s lab at the Salk Institute using a mouse model of sepsis. By analyzing neural-system signaling that correlates with survival, Bond is uncovering how the nervous and immune systems communicate to help the host survive an infection. In addition to discovering fundamental principles about cooperative defense, her work may lead to new ideas for improving outcomes for people with sepsis.
University of California, Berkeley
Read more
Awarded Organization: University of California, Berkeley
Awarded Department: Department of Molecular and Cellular Biology
Sponsor: Dr. Nicole KingAward Year Start: 2015
Current Organization: University of California, San Francisco
Current Department: Department of Biochemistry and Biophysics
Current Title: Assistant Professor
Project Title: Genetic regulation of multicellularity in a close relative to metazoans
The evolution of regulatory mechanisms to coordinate multicellular development was critical to the origin of animals. Fundamental mechanisms that led to animal multicellularity may also be conserved in the closest living relative of animals, the choanoflagellates, since one species, Salpingoeca rosetta, can transition to a multicellular form called a rosette in a process that is reminiscent of early embryogenesis in animals. To uncover how this multicellular transition is controlled in S. rosetta, we are establishing transgenic and genomic methods that will enable investigating how genes coordinate rosette development. These advances will provide essential tools for exploring the molecular biology of these ecologically and evolutionarily important organisms and potentially illuminate the earliest stages of animal evolution and development.
Awarded Organization: University of Washington
Awarded Department: Department of Genetics
Sponsor: Dr. Herschel L. RomanAward Year Start: 1974
Project Title: Molecular analysis of yeast DNA
University of Wisconsin, Madison
Read more
Awarded Organization: University of Wisconsin, Madison
Awarded Department: Laboratory of Molecular Biophysics
Sponsor: Dr. Judith E. KimbleAward Year Start: 1994
Current Organization: Yale University School of Medicine
Current Department: Department of Dermatology, Pathology and Immunobiology
Current Title: Professor
Project Title: Characterization of signal transductions
Awarded Organization: Cold Spring Harbor Laboratory
Awarded Department: Center for Cancer Research
Sponsor: Dr. Joe Sambrook & David BaltimoreAward Year Start: 1975
Current Organization: University of Arizona
Current Department: Department of Immunobiology
Current Title: Professor
Project Title: kPost-transcriptional controls of animal viruses
Awarded Organization: Stanford University
Awarded Department: Department of Radiation Oncology
Sponsor: Dr. Laura AttardiAward Year Start: 2014
Current Organization: 10x Genomics
Current Title: Technical Support Manager
Project Title: Consequences of P53 activation during development
The p53 protein is a transcription factor that becomes activated in response to various cellular stress cues. Once activated, p53 induces target genes involved in apoptosis, cell cycle arrest, senescence and differentiation. Maintaining the correct levels of p53 is critical, since loss of p53 promotes cancer, while increased p53 activity promotes developmental defects and premature aging. To further define the consequences of increased p53 activity, the Attardi lab created a novel mouse model in which p53 is activated during embryogenesis. Intriguingly, this led to a variety of craniofacial and cardiovascular defects. This unique constellation of phenotypes is reminiscent of human CHARGE syndrome, which is caused by mutations in CHD7. I am now using our p53 mouse models to study the cellular and molecular mechanisms by which p53 promotes features of CHARGE syndrome. These studies will further our understanding of p53 as a mediator of developmental disease in addition to its role as a tumor suppressor.
Awarded Organization: Fred Hutchinson Cancer Center
Sponsor: Dr. James R. PriessAward Year Start: 1989
Current Organization: University of Oregon
Current Department: Department of Biology
Current Title: Professor
Project Title: Early determinants of neuronal fate in the nematode
Awarded Organization: University of Pennsylvania
Awarded Department: Department of Cell and Developmental Biology
Sponsor: Dr. Roberto BonasioAward Year Start: 2019
Project Title: Molecular regulation of behavioral and reproductive plasticity in ants
Awarded Organization: Australian National University
Awarded Department: John Curtin School of Medical Research
Sponsor: Dr. Robert V. BlandenAward Year Start: 1976
Project Title: Cell-mediated cytotoxicity to influenza virus
Awarded Organization: Rockefeller University
Awarded Department: Department of Biochemistry
Sponsor: Dr. Gerald M. EdelmanAward Year Start: 1975
Current Organization: University of Cincinnati
Current Title: Professor Emeritus
Project Title: Molecular mechanisms of cell-cell interactions
Awarded Organization: Stanford University
Awarded Department: Department of Neurobiology
Sponsor: Dr. Howard SchulmanAward Year Start: 2001
Current Organization: Alumis
Current Title: Executive Director
Project Title: Calmodulin binding and trapping by CaM kinase II
Awarded Organization: Massachusetts General Hospital
Awarded Department: Cardiovascular Research Center
Sponsor: Dr. Randall PetersonAward Year Start: 2012
Current Organization: Nuvation Bio
Current Department: Medical Writing
Current Title: Director
Project Title: Driving differentiation of retinal glia
Awarded Organization: Stanford University
Awarded Department: Department of Biochemistry
Sponsor: Dr. James E. RothmanAward Year Start: 1981
Project Title: ATP-dependent clathrin disassembly
Awarded Organization: California Institute of Technology
Awarded Department: Division of Biology and Biological Engineering
Sponsor: Dr. Zhen ChenAward Year Start: 2024
Current Title: Postdoctoral Fellow
Project Title: Defining the role of protein homeostasis in spermatogenesis
Traditionally, structural biology efforts have been limited to studying purified samples in isolation. While we have learned a great deal via these efforts, such approaches unfortunately strip away much of the biological context from the sample of interest.
Dr. Julian Braxton will overcome these limitations by using cryo-electron tomography (cryo-ET) to examine proteostasis, or the process by which cells maintain the proper balance, folding, and function of proteins, within sperm cells in Dr. Zhen Chen’s lab at the California Institute of Technology. Proteostasis plays important yet understudied roles in cellular development processes, as the proteome must be reprogrammed to enable new functions. Braxton will apply cellular cryo-ET to analyze such developmental processes in mammalian sperm, where highly specialized functional compartments are assembled. This research will provide foundational understanding into the posttranslational regulation of sperm maturation and expand the frontier of cryo-ET development and analysis.
Braxton’s expertise in proteostasis stems from his graduate studies in Dr. Daniel Southworth’s lab at the University of California, San Francisco. There, Braxton used the related structural technique cryo-EM to reveal the intricate details of how the autophagy-related adapter UBXD1 regulates the hexameric AAA+ chaperone p97. His findings revealed that UBXD1 separates two adjacent p97 protomers to open the p97 ring, allowing for a new mode of substrate entry and/or exit into the p97 central pore. In a related project, Braxton revealed a novel asymmetric state of the mitochondrial chaperone Hsp60 that enables client refolding. In his postdoctoral work, Braxton will expand his structural biology toolkit to include cryo-ET and use this technique to provide unprecedented insight into the role of nuclear proteasomes in spermatogenesis.
Awarded Organization: University of Colorado, Boulder
Awarded Department: Department of Molecular, Cellular and Developmental Biology
Sponsor: Dr. Ding XueAward Year Start: 2003
Current Organization: Actio Biosciences
Current Title: Chief Scientific Officer
Project Title: Role of mitochondria during apoptosis in C elegans
Awarded Organization: Stanford University
Awarded Department: Department of Biochemistry
Sponsor: Dr. Paul BergAward Year Start: 1964
Current Organization: MRC Laboratory of Molecular Biology
Current Department: Cell Biology Division
Current Title: �Emeritus scientist
Project Title: Nucleic acid metabolism and protein synthesis
Awarded Organization: Stanford University
Awarded Department: Department of Chemical and Systems Biology
Sponsor: Dr. Karlene CimprichAward Year Start: 2020
Current Organization: Stanford University
Current Department: Department of Chemistry and Systems Biology
Current Title: Postdoctoral Fellow
Project Title: Mechanisms of R-loop mediated innate immune response in non-dividing cells
Awarded Organization: Washington University in St. Louis
Awarded Department: Department of Internal Medicine
Sponsor: Dr. Stuart KornfeldAward Year Start: 1974
Project Title: Mitogenic effects of certain lectins
Awarded Organization: University of Washington
Awarded Department: Department of Zoology
Sponsor: Dr. Charles LairdAward Year Start: 1982
Current Organization: University of British Columbia
Current Department: Provost's Office
Current Title: Professor Emeritus
Project Title: Dosage compensation in Drosophila LSPI-alpha genes
Awarded Organization: University of Minnesota, Twin Cities
Awarded Department: Neurosurgery Department
Sponsor: Dr. Andrew Venteicher, MD, PhDAward Year Start: 2021
Current Organization: University of Minnesota
Current Title: Postdoctoral Fellow
Project Title: The role of the
Human chordoma is a locally aggressive and invasive type of cancer that occurs in the bones of the skull base and spine, and it is part of a group of malignant bone and soft tissue tumors called sarcomas. It is characterized by high recurrence rates and a lack of chemotherapy response. Although studies using exome sequencing identified a few genetic alterations, the vast majority of chordomas do not appear to have a causal genetic mutation, given that the overall somatic mutation burden in chordoma is modest. Recently, the Chordoma Genome Project provided essential clues about novel genes implicated in chordoma tumorigenesis. DNA sequencing revealed that mutations in the gene encoding the lysosomal trafficking regulator protein (LYST) have a role in chordoma biology, as recurrent truncating mutations were found in 10% of tumors. Our lab has preliminary data suggesting that epigenetic regulation of LYST leads to a clinically aggressive chordoma variant, marked by reduced survival and a high rate of metastasis. Herein, this research focuses on elucidating the mechanisms of epigenetic regulation of chordoma-related genes, like LYST, by applying chromosome conformation capture and protein-DNA interaction techniques. Initial findings have shown differences in chromatin accessibility and conformation between tumor subtypes, suggesting an association with the patient’s prognosis.
St. Jude Children's Research Hospital
Read more
Awarded Organization: St. Jude Children's Research Hospital
Awarded Department: Department of Structural Biology
Sponsor: Dr. Brenda SchulmanAward Year Start: 2012
Current Organization: University of North Carolina, Chapel Hill
Current Department: Department of Pharmacology, Lineberger Comprehensive Cancer Center
Current Title: Associate Professor
Project Title: Anaphase-promoting complex ubiquitination mechanisms
Massachusetts Institute of Technology
Read more
Awarded Organization: Massachusetts Institute of Technology
Awarded Department: Department of Biology
Sponsor: Dr. Tania BakerAward Year Start: 2013
Current Organization: Vanderbilt University
Current Department: Department of Biochemistry
Current Title: Assistant Professor
Project Title: Elucidating the role of the E. coli Lon protease N-domain in substrate recognition and discrimination
My primary research interest is studying the molecular basis of the diverse protein-protein interactions that underlie bacterial cell signaling. I am currently focusing on determining the various types of substrate interactions mediated by the E. coli Lon protease to understand how this critical regulator degrades certain proteins during cellular stress. Lon is one of the major proteases that mediates protein quality control via degradation of over half of the unfolded or misfolded proteins in the cell. Additionally, Lon degrades stably-folded regulatory proteins involved in response to several stresses such as DNA damage, heat shock, and oxidation. Using a combination of biophysical and biochemical assays, including electron microscopy, X- ray crystallography, analytical ultracentrifugation, and enzyme kinetics, my current goal is to identify the molecular interactions critical for Lon self-assembly and substrate recognition. With this detailed information, we can begin to understand in greater detail how Lon discriminates among various substrates to regulate critical cellular stress responses and survival.
Awarded Organization: University of Oregon
Awarded Department: Institute of Molecular Biology
Sponsor: Dr. George F. Sprague Jr.Award Year Start: 1991
Project Title: Receptor-mediated signal transduction in yeast
Awarded Organization: Brigham and Women's Hospital
Awarded Department: Department of Medicine
Sponsor: Dr. Stephen J. ElledgeAward Year Start: 2017
Current Organization: University of California, San Francisco
Current Department: Department of Urology
Current Title: Assistant Professor
Project Title: The role of ZNF292 in senescence and tumorigenesis
Senescence is an irreversible cell state characterized by permanent exit from the cell cycle that occurs in response to cellular stresses such as shortened telomeres and DNA damage. Thus, senescent cells accumulate as an organism ages and are thought to contribute to the gradual decline in tissue function as we age. Importantly, elimination of senescent cells in old mice extends healthy lifespan. Therefore, achieving a better understanding of the genetic underpinnings of senescence can lead to improved prevention and treatment of aging-related diseases._x000D_
_x000D_
It is currently thought that senescence is mediated by three distinct pathways, characterized by their primary facilitators: p53, p16 and GATA4. However, there are likely many more factors that are critical to senescence induction. Thus, we conducted a whole genome CRISPR screen for genes necessary for replicative senescence in IMR90 primary fibroblasts. One novel gene identified was ZNF292. Thus, the objective of my postdoctoral work is to gain a more thorough understanding of the role of ZNF292 in senescence and tumorigenesis._x000D_
_x000D_
_x000D_
_x000D_
Awarded Organization: Harvard University
Awarded Department: Department of Biochemistry and Molecular Biology
Sponsor: Dr. Tom ManiatisAward Year Start: 1991
Current Organization: Saba University
Current Department: Department of Basic Science
Current Title: Executive Dean
Project Title: D. melanogaster tra-2 function in the male germ line
Awarded Organization: Yale University
Awarded Department: Department of Microbiology
Sponsor: Dr. Edward AdelbergAward Year Start: 1973
Project Title: Quantitation of chromosomal content in cell fusion hybrids
Awarded Organization: Princeton University
Awarded Department: Department of Biology
Advisor Name: Iva GreenwaldAwarded Sponsor: Princeton University
Award Year Start: 1988
Project Title: Genetic and molecular analysis of C. elegans lineages
Awarded Organization: Harvard Medical School
Awarded Department: Department of Systems Biology
Sponsor: Dr. Galit LahavAward Year Start: 2021
Current Organization: Incendia Therapeutics
Current Title: Senior Scientist
Project Title: The role of p53 dynamics in immune cell regulation
In response to DNA damage, the tumor suppressor protein p53 induces expression of stress-responsive genes to inhibit proliferation of cells with damaged DNA. Changes in p53 protein levels over time (p53 dynamics) impact cellular outcomes: p53 oscillations facilitate repair of DNA-damaged cells, whereas sustained levels of p53 promote senescence and cell death. While it is now established that p53 dynamics contribute to these competing cell-autonomous processes, how p53 dynamics regulate genes involved in non-cell-autonomous events, such as those involved in immune signaling, is not known. I propose to develop new tools and approaches to study the role of p53 in regulating immune gene expression in cancer cells and in mediating the killing of cancer cells by immune cells. This research will provide fundamental insights into the mechanisms that govern of cancer cell-immune cell interactions and pave the way for developing effective combination therapies to treat cancer
Awarded Organization: Cold Spring Harbor Laboratory
Sponsor: Dr. David ZipserAward Year Start: 1971
Project Title: Temperate phage Mu-1 in chromosome replication
Awarded Organization: Cold Spring Harbor Laboratory
Sponsor: Dr. David ZipserAward Year Start: 1971
Project Title: Temperate phage Mu-1 in chromosome of E. coli
Awarded Organization: University of Colorado, Boulder
Awarded Department: Department of Biochemistry
Sponsor: Dr. Aaron T. WhiteleyAward Year Start: 2025
Current Title: Postdoctoral Fellow
Project Title: Unlocking the Bacterial Vault: Novel Organelles Involved in RNA Repair
It has been said that RNA is the central molecule in genetic transfer and cellular processes; Dr. Nathan Bullen’s past and planned future research certainly support that sentiment.
During his thesis research in Dr. John Whitney’s lab at McMaster University, Bullen discovered the role of an RNA-modifying enzyme in microbial warfare. Bacteria compete with one another in a microscopic turf war of sorts. One of the ways they combat their foes is by injecting toxins into nearby bacterial cells. Bullen demonstrated that one of these toxins is an enzyme called RhsP2 which works to inhibit protein synthesis or translation in neighboring cells.
As a Fellow in Aaron Whiteley’s lab at the University of Colorado, Dr. Bullen is going on the defensive—asking: how do organisms survive when their RNA is under attack? Intriguingly, the proteins that repair RNA are conserved from bacteria to humans, and Bullen has reason to believe that these systems operate in remarkably similar ways, despite billions of years of evolution. By studying these pathways in bacteria—whose genes are easier to manipulate—his cutting-edge research is shedding light on fundamental processes of RNA metabolism across the tree of life, with far-reaching implications for health, disease, and beyond.
University of California, Los Angeles
Read more
Awarded Organization: University of California, Los Angeles
Awarded Department: Department of Human Genetics
Sponsor: Dr. Leonid KruglyakAward Year Start: 2013
Current Organization: OAW - Austrian Academy of Sciences
Current Department: Institute of Molecular Biotechnology
Current Title: Group Leader
Project Title: A novel bulk segregant method to identify natural genetic variants underlying Caenorhabditis elegans resistance to chemotherapy drugs
Massachusetts Institute of Technology
Read more
Awarded Organization: Massachusetts Institute of Technology
Awarded Department: David H. Koch Institute for Integrative Cancer Research
Sponsor: Dr. Tyler JacksAward Year Start: 2016
Current Organization: Oregon Health and Science University
Current Department: Department of Cell, Developmental and Cancer Biology
Current Title: Assistant Professor
Project Title: Investigating mechanisms of immune evasion in autochthonous lung tumors
Awarded Organization: University of Washington
Awarded Department: Department of Genetics
Sponsor: Dr. Leland HartwellAward Year Start: 1983
Current Organization: University of Virginia
Current Department: Department of Biochemistry and Molecular Genetics
Current Title: Professor
Project Title: Genetic analysis of centromere replication
Awarded Organization: National Institutes of Health
Sponsor: Dr. B.L. Horecker & H.M. KalckarAward Year Start: 1956
Current Organization: Banaras Hindu University
Project Title: Synthesis of carbohydrates in plants by enzymatic methods
Awarded Organization: University of Oxford
Awarded Department: Department of Biochemistry
Sponsor: Dr. June LascellesAward Year Start: 1961
Current Organization: University of Utah
Current Department: Department of Chemistry,
Project Title: Tumor enzymology